malondialdehyde has been researched along with Coxsackie Virus Infections in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, G; Sun, L; Xu, H; Yang, L | 1 |
Chen, F; Cheng, YB; Cui, YJ; Li, P; Song, CL | 1 |
Liu, L; Qian, H | 1 |
Ding, Y; Sun, X; Wang, H; Wang, S; Zhou, J | 1 |
Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y | 1 |
Beck, MA; Chu, FF; Esworthy, RS; Ho, YS | 1 |
1 trial(s) available for malondialdehyde and Coxsackie Virus Infections
Article | Year |
---|---|
[Myocardial protective effect of L-carnitine in children with hand, foot and mouth disease caused by Coxsackie A16 virus].
Topics: Carnitine; Child, Preschool; Coxsackievirus Infections; Female; Hand, Foot and Mouth Disease; Heart; Humans; Infant; Male; Malondialdehyde; Myocardium; Superoxide Dismutase | 2017 |
5 other study(ies) available for malondialdehyde and Coxsackie Virus Infections
Article | Year |
---|---|
IDO1 depletion induces an anti-inflammatory response in macrophages in mice with chronic viral myocarditis.
Topics: Animals; Coculture Techniques; Coxsackievirus Infections; Cytokines; Disease Models, Animal; Electrocardiography; Enterovirus; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation; L-Lactate Dehydrogenase; Macrophages; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Myocarditis; Myocytes, Cardiac; Signal Transduction; Transfection; Tryptophan; Up-Regulation | 2019 |
[Protective effect of hydrogen sulfide on mice with experimental viral myocarditis and its mechanism].
Topics: Animals; Blotting, Western; Catalase; Coxsackievirus Infections; Enterovirus; Enzyme-Linked Immunosorbent Assay; Glutathione Peroxidase; HeLa Cells; Host-Pathogen Interactions; Humans; Hydrogen Sulfide; Interleukin-1beta; Interleukin-6; Malondialdehyde; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Protective Agents; Random Allocation; Sulfides; Superoxide Dismutase; Transcription Factor RelA; Troponin I; Tumor Necrosis Factor-alpha | 2014 |
The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3.
Topics: Animals; Antiviral Agents; Coxsackievirus Infections; Cytokines; Enterovirus B, Human; Enzymes; Glucosides; Heart; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Myocardium; Phenols; Phytotherapy; Rats; Rats, Sprague-Dawley; Rhodiola; RNA, Messenger; Superoxide Dismutase | 2009 |
Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Carbazoles; Cardiotonic Agents; Carvedilol; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Interleukins; Male; Malondialdehyde; Metoprolol; Mice; Mice, Inbred BALB C; Myocarditis; Propanolamines; Quinazolines; Superoxide Dismutase; Up-Regulation | 2008 |
Glutathione peroxidase protects mice from viral-induced myocarditis.
Topics: Animals; Catalase; Coxsackievirus Infections; Enterovirus B, Human; Genome, Viral; Glutathione Peroxidase; Inflammation; Liver; Malondialdehyde; Mice; Mice, Knockout; Myocarditis; Myocardium; Point Mutation | 1998 |